Paris-based Novacyt SA has signed a global distribution agreement with Bruker Ltd for its COVID-19 diagnostic test.
AC Immune SA has received a milestone payment of CHF10m from Eli Lilly and Company.
Scientists have discussed a link between Covid-19 and sepsis at a virtual symposium at Charité Berlin that might help reduce the burden of end-stage disease.
Evonik Industries has established a new animal-free and fermentation-based industrial-scale recombinant collagen production platform.
Chinese Fosun Pharma Ltd has made the largest investment in a foreign company for a COVID-19 vaccine development: BioNTechd mRNA vaccine BNT162.
Under its Green Deal, the European Commission has presented a circular (bio)economay action plan that prepares the ground for a sustainable bio-economy.
Researchers at Swiss pharma giant Roche AG have found a subpopulation of dendritic cells to determine how cancer patients respond to immune checkpoint inhibitors.
New data prove that propionic acid modulates the intestine-mediated immune regulation in people with multiple sclerosis (MS).
LSP has closed its LSP 6 fund at the $600m hard cap. It is the largest fund ever raised in Europe focused on life sciences ventures.
Pest control specialist Biotalys NV has raised an additional €10m to its series C financing bringing its amount to €45m.